Manulife (Manufacturers Life Insurance)
CLPT icon

Manulife (Manufacturers Life Insurance)’s ClearPoint Neuro CLPT Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-10,388
Closed -$70.6K – 2980
2024
Q1 		$70.6K Buy
10,388
+83
+0.8% +$580 ﹤0.01% 2856
2023
Q4 		$70K Hold
10,305
– – ﹤0.01% 2891
2023
Q3 		$51.6K Hold
10,305
– – ﹤0.01% 2939
2023
Q2 		$74.6K Buy
+10,305
New +$87.7K ﹤0.01% 2929
2022
Q1 		– Sell
-10,508
Closed -$118 – 3088
2021
Q4 		$118 Buy
10,508
+254
+2% +$3.8K ﹤0.01% 3032
2021
Q3 		$182K Sell
10,254
-825
-7% -$15.5K ﹤0.01% 3013
2021
Q2 		$211K Buy
+11,079
New +$214K ﹤0.01% 3069

Other funds holding CLPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CWM
Cahill Wealth Management Portage, Michigan $196M AUM 8.5% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s CLPT Position: Q2 2024 in Review

Manulife (Manufacturers Life Insurance) sold out of ClearPoint Neuro (CLPT) in Q2 2024, closing a stake of 10,388 shares — an estimated $70.6K sold.

Manulife (Manufacturers Life Insurance) first reported a position in CLPT in Q2 2021 and held it in 7 quarters. The position peaked at $211K in Q2 2021. 86 funds tracked by Wall St. Rank hold CLPT as of Q2 2024.

  • Manulife (Manufacturers Life Insurance) reported no remaining ClearPoint Neuro position as of Q2 2024 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 10,388 ClearPoint Neuro shares in Q2 2024, an estimated $70.6K.
  • Manulife (Manufacturers Life Insurance) first reported a position in ClearPoint Neuro in Q2 2021 and held it in 7 quarters.
  • Manulife (Manufacturers Life Insurance)'s ClearPoint Neuro position peaked at $211K in Q2 2021.
  • 86 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2024.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2024, filed 14 Aug 2024.